GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Provexis PLC (LSE:PXS) » Definitions » Inventories, Finished Goods

Provexis (LSE:PXS) Inventories, Finished Goods : £0.14 Mil (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Provexis Inventories, Finished Goods?

Provexis's quarterly finished goods declined from Mar. 2023 (£0.33 Mil) to Sep. 2023 (£0.00 Mil) but then increased from Sep. 2023 (£0.00 Mil) to Mar. 2024 (£0.14 Mil).

Provexis's annual finished goods increased from Mar. 2022 (£0.09 Mil) to Mar. 2023 (£0.33 Mil) but then declined from Mar. 2023 (£0.33 Mil) to Mar. 2024 (£0.14 Mil).

Provexis Inventories, Finished Goods Historical Data

The historical data trend for Provexis's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Provexis Inventories, Finished Goods Chart

Provexis Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.06 0.09 0.33 0.14

Provexis Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 - 0.33 - 0.14

Provexis Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Provexis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Provexis PLC (LSE:PXS) » Definitions » Inventories, Finished Goods
Comparable Companies
LSE:CEL LSE:N4P LSE:STX LSE:EAH ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS HKSE:03692 SZSE:000538 NBIX NSE:TORNTPHARM BOM:543904 BOM:500124
Traded in Other Exchanges
PXS.GB:UK
Address
2 Blagrave Street, I Ford, Reading, Berkshire, GBR, RG1 1AZ
Website
https://www.provexis.com
Provexis PLC is a British food company. It is engaged in developing and licensing the Fruitflow, which is patented, natural, breakthrough ingredient which helps with platelet aggregation. Fruitflow reduces the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can result in heart attack and stroke. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.